WAY-100635 is a potent dopamine D4 receptor agonist (Q28258364)

2

0 references

Blaine Armbruster

3

0 references

Val J Watts

4

0 references

David E Nichols

https://scigraph.springernature.com/pub.10.1007/s00213-006-0490-4

5

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

Psychopharmacology

0 references

volume

188

0 references

issue

2

0 references

page(s)

244-51

0 references

exact match

0 references

cites work

Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system

1 reference

12 December 2020

The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.

1 reference

12 December 2020

Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors

1 reference

12 December 2020

Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey u

1 reference

12 December 2020

A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT(1A) receptor PET radioligands

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

1 reference

12 December 2020

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

1 reference

12 December 2020

2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.

1 reference

12 December 2020

First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635

1 reference

12 December 2020

In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors.

1 reference

12 December 2020

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

12 December 2020

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

1 reference

12 December 2020

Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand.

1 reference

12 December 2020

Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635

1 reference

12 December 2020